Xiamen Jingchuang International Trade Co., Ltd. – Trademark Portfolio
Entity Type: 99
Xiamen Jingchuang International Trade Co., Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include BAWOPA, KKMULL, KKSSOP, OPPWOW, and OPTIMAL AURA. The owner is based in Xiamen, Fujian.
Siming District
Unit 1703-5, No. 171, Tapu East Road
Xiamen, Fujian 361000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xiamen Jingchuang International Trade Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Xiamen Jingchuang International Trade Co., Ltd. have?
Xiamen Jingchuang International Trade Co., Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Xiamen Jingchuang International Trade Co., Ltd. file in?
Xiamen Jingchuang International Trade Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Xiamen Jingchuang International Trade Co., Ltd.'s most well-known trademarks?
Xiamen Jingchuang International Trade Co., Ltd.'s registered trademark portfolio includes well-known marks such as BAWOPA, KKMULL, KKSSOP, OPPWOW, and OPTIMAL AURA. These are among 5 currently registered trademarks in the portfolio.
What is Xiamen Jingchuang International Trade Co., Ltd.'s trademark registration success rate?
Xiamen Jingchuang International Trade Co., Ltd. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.